These TDP-43 signaling alterations have been associated with cancers, either as a tumor promoter (upregulated in breast, lung, hepatocellular cancer, or glioblastoma), or as tumor suppressor (downregulated in cervical cancer, colon, neuroblastoma, and others) [114]. Here, TARDBP is linked to neoplasm.